Effectiveness and adverse events of ivermectin treatment for scabies in 30 infant patients: report from a German single centre

J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e736-e737. doi: 10.1111/jdv.16554. Epub 2020 Jun 8.

Authors

S Ständer¹, D J Kirschstein², M Kohl-Sobania², D Zillikens^{1

3}, R J Ludwig^{3

4}, W Anemüller¹

Affiliations

¹ Department of Dermatology, University of Lübeck, Lübeck, Germany.
² Department of Pediatrics, University of Lübeck, Lübeck, Germany.
³ Center for Research on Inflammation of the Skin, University of Lübeck, Lübeck, Germany.
⁴ Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

PMID: 32339346
DOI: 10.1111/jdv.16554

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Antiparasitic Agents / adverse effects
Humans
Infant
Insecticides* / therapeutic use
Ivermectin / adverse effects
Scabies* / drug therapy
Treatment Outcome

Substances

Antiparasitic Agents
Insecticides
Ivermectin

Grants and funding